MTA1 aids the AKT pathway by inhibiting expression of a key regulator, PTEN

Journal of Cancer Science and Therapy

Volumn 2, Issue 4, 2010, Pages 114-119

  Salot, Shimul ^a   Gude, Rajiv ^a  

^a TATA MEMORIAL HOSPITAL   (India)

Author keywords

AKT; Breast cancer; Histone deacetylation; Metastasis; MTA1; PI3K; PTEN

Indexed keywords

CALVASCULIN; HISTONE DEACETYLASE; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; SMALL INTERFERING RNA;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CONTROLLED STUDY; DEACETYLATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 77954961890     PISSN: None     EISSN: 19485956     Source Type: Journal    
DOI: 10.4172/1948-5956.1000034     Document Type: Article

References (36)

1. Alessi DR, James SR, Downes CP, Holmes AB, Gaffney PR, et al. (1997) Characterization of a 3-phosphoinositide-dependent protein inase which phosphorylates and activates protein kinase Balpha. Curr Biol 7: 261-269.
2. Aramaki Y, Ogawa K, Toh Y, Ito T, Akimitsu N, et al. (2005) Direct interaction between metastasis-associated protein 1 and endophilin 3. FEBS Lett 579: 3731-3736.
3. Balasenthil S, Broaddus RR, Kumar R (2006) Expression of metastasisassociated protein 1 (MTA1) in benign endometrium and endometrial adenocarcinomas. Hum Pathol 37: 656-661.
4. Balasenthil S, Gururaj AE, Talukder AH, Bagheri-Yarmand R, Arrington T, et al. (2007) Identification of Pax5 as a target of MTA1 in B-cell lymphomas. Cancer Res 67: 7132-7138.
5. Bellacosa A, Chan TO, Ahmed NN, Datta K, Malstrom S, et al. (1998) Akt activation by growth factors is a multiple-step process: the role of the PH domain. Oncogene 17: 313-325.
6. Caron C, Boyault C, Khochbin S (2005) Regulatory cross-talk between lysine acetylation and ubiquitination: role in the control of protein stability. Bioessays 27: 408-415.
7. Chambers AF, Groom AC, MacDonald IC (2002) Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2: 563-572.
8. Gururaj AE, Holm C, Landberg G, Kumar R (2006a) Breast cancer-amplified sequence 3, a target of metastasis-associated protein 1, contributes to tamoxifen resistance in premenopausal patients with breast cancer. Cell Cycle 5: 1407-1410.
9. Gururaj AE, Singh RR, Rayala SK, Holm C, den Hollander P, et al. (2006b) MTA1, a transcriptional activator of breast cancer amplified sequence 3. Proc Natl Acad Sci U S A 103: 6670-6675.
10. Jang KS, Paik SS, Chung H, Oh YH, Kong G (2006) MTA1 overexpression correlates significantly with tumor grade and angiogenesis in human breast cancers. Cancer Sci 97: 374-379.
11. Kawasaki G, Yanamoto S, Yoshitomi I, Yamada S, Mizuno A (2008) Overexpression of metastasis-associated MTA1 in oral squamous cell carcinomas: correlation with metastasis and invasion. Int J Oral Maxillofac Surg 37: 1039-1046.
12. Khaleque MA, Bharti A, Gong J, Gray PJ, Sachdev V, et al. (2008) Heat shock factor 1 represses estrogen-dependent transcription through association with MTA1. Oncogene 27: 1886-1893.
13. Li J, Yen C, Liaw D, Podsypanina K, Bose S, et al. (1997) PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275: 1943-1947.
14. Maehama T, Dixon JE (1998) The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem 273: 13375-13378.
15. Manavathi B, Peng S, Rayala SK, Talukder AH, Wang MH, et al. (2007) Repression of Six3 by a corepressor regulates rhodopsin expression. Proc Natl Acad Sci USA 104: 13128-13133.
16. Martin MD, Fischbach K, Osborne CK, Mohsin SK, Allred DC, et al. (2001) Loss of heterozygosity events impeding breast cancer metastasis contain the MTA1 gene. Cancer Res 61: 3578-3580.
17. Martin MD, Hilsenbeck SG, Mohsin SK, Hopp TA, Clark GM, et al. (2006) Breast tumors that overexpress nuclear metastasis-associated 1 (MTA1) protein have high recurrence risks but enhanced responses to systemic therapies. Breast Cancer Res Treat 95: 7-12.
18. Mishra SK, Mazumdar A, Vadlamudi RK, Li F, Wang RA, et al. (2003) MICoA, a novel metastasis-associated protein 1 (MTA1) interacting protein coactivator, regulates estrogen receptor-alpha transactivation functions. J Biol Chem 278: 19209-19219.
19. Pinto M, Vieira J, Ribeiro FR, Soares MJ, Henrique R, et al. (2008) Overexpression of the mitotic checkpoint genes BUB1 and BUBR1 is associated with genomic complexity in clear cell kidney carcinomas. Cell Oncol 30: 389-395.
20. Saal LH, Gruvberger-Saal SK, Persson C, Lovgren K, Jumppanen M, et al. (2008) Recurrent gross mutations of the PTEN tumor suppressor gene in breast cancers with deficient DSB repair. Nat Genet 40: 102-107.
21. Sasaki H, Moriyama S, Nakashima Y, Kobayashi Y, Yukiue H, et al. (2002) Expression of the MTA1 mRNA in advanced lung cancer. Lung Cancer 35: 149-154.
22. Sasaki H, Yukiue H, Kobayashi Y, Nakashima Y, Kaji M, et al. (2001) Expression of the MTA1 mRNA in thymoma patients. Cancer Lett 174: 159-163.
23. Stambolic V, Suzuki A, de la Pompa JL, Brothers GM, Mirtsos C, et al. (1998) Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 95: 29-39.
24. Steck PA, Pershouse MA, Jasser SA, Yung WK, Lin H, et al. (1997) Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 15: 356-362.
25. Stokoe D, Stephens LR, Copeland T, Gaffney PR, Reese CB, et al. (1997) Dual role of phosphatidylinositol-3,4,5-trisphosphate in the activation of protein kinase B. Science 277: 567-570.
26. Talukder AH, Gururaj A, Mishra SK, Vadlamudi RK, Kumar R (2004) Metastasisassociated protein 1 interacts with NRIF3, an estrogen-inducible nuclear receptor coregulator. Mol Cell Biol 24: 6581-6591.
27. Talukder AH, Mishra SK, Mandal M, Balasenthil S, Mehta S, et al. (2003) MTA1 interacts with MAT1, a cyclin-dependent kinase-activating kinase complex ring finger factor, and regulates estrogen receptor transactivation functions. J Biol Chem 278: 11676-11685.
28. Toh Y, Kuwano H, Mori M, Nicolson GL, Sugimachi K (1999) Overexpression of metastasis-associated MTA1 mRNA in invasive oesophageal carcinomas. Br J Cancer 79: 1723-1726.
29. Toh Y, Oki E, Oda S, Tokunaga E, Ohno S, et al. (1997) Overexpression of the MTA1 gene in gastrointestinal carcinomas: correlation with invasion and metastasis. Int J Cancer 74: 459-463.
30. Toh Y, Pencil SD, Nicolson GL (1994) A novel candidate metastasisassociated gene, mta1, differentially expressed in highly metastatic mammary adenocarcinoma cell lines. cDNA cloning, expression, and protein analyses. J Biol Chem 269: 22958-22963.
31. Toh Y, Pencil SD, Nicolson GL (1995) Analysis of the complete sequence of the novel metastasis-associated candidate gene, mta1, differentially expressed in mammary adenocarcinoma and breast cancer cell lines. Gene 159: 97-104.
32. Tsai WC, Chao YC, Sheu LF, Chang JL, Nieh S, et al. (2007) Overexpression of fascin-1 in advanced colorectal adenocarcinoma: tissue microarray analysis of immunostaining scores with clinicopathological parameters. Dis Markers 23: 153-160.
33. Vanhaesebroeck B, Alessi DR (2000) The PI3K-PDK1 connection: more than just a road to PKB. Biochem J 346 Pt 3: 561-576.
34. Vivanco I, Sawyers CL (2002) The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev Cancer 2: 489-501.
35. Xue Y, Wong J, Moreno GT, Young MK, Cote J, et al. (1998) NURD, a novel complex with both ATP-dependent chromatin-remodeling and histone deacetylase activities. Mol Cell 2: 851-861.
36. Yao YL, Yang WM (2003) The metastasis-associated proteins 1 and 2 form distinct protein complexes with histone deacetylase activity. J Biol Chem 278: 42560-42568.